Atlas FDA

Restylane Refyne, Restylane Defyne, Restylane Kysse

FDA premarket approval P140029/S040 · decided 2021-10-19

Approval details

PMA number
P140029
Supplement
S040
Supplement type
135 Review Track For 30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Restylane Refyne, Restylane Defyne, Restylane Kysse
Generic name
Implant, dermal, for aesthetic use
Applicant
Q-Med AB
Date received
2021-06-02
Decision date
2021-10-19
Days to decision
139 days
Decision code
APPR
Product code
LMH
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Uppsala
Statement
Approval for a new alternative bulk process on one manufacturing line to produce flexible batch sizes.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.